These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34929569)

  • 1. l-Asparaginase and HCP quantification by SWATH LC-MS/MS for new and improved purification step in Erwinia chrysanthemil-asparaginase manufacture.
    Modi T; Regufe da Mota S; Gervais D
    J Pharm Biomed Anal; 2022 Feb; 209():114537. PubMed ID: 34929569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
    Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
    Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteins from Erwinia asparaginase Erwinase ® and E. coli asparaginase 2 MEDAC ® for treatment of human leukemia, show a multitude of modifications for which the consequences are completely unclear.
    Bae N; Pollak A; Lubec G
    Electrophoresis; 2011 Jul; 32(14):1824-8. PubMed ID: 21769889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a 30-year-old process for the manufacture of L-asparaginase from Erwinia chrysanthemi.
    Gervais D; Allison N; Jennings A; Jones S; Marks T
    Bioprocess Biosyst Eng; 2013 Apr; 36(4):453-60. PubMed ID: 22907565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia.
    Salzer WL; Asselin BL; Plourde PV; Corn T; Hunger SP
    Ann N Y Acad Sci; 2014 Nov; 1329():81-92. PubMed ID: 25098829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asparaginase Erwinia chrysanthemi (Erwinaze®): a guide to its use in acute lymphoblastic leukemia in the USA.
    Keating GM
    BioDrugs; 2013 Aug; 27(4):413-8. PubMed ID: 23794007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the analytical toolbox to investigate copurifying host cell proteins presence: N-(4)-(β-acetylglucosaminyl)- l-asparaginase case study.
    Clavier S; Fougeron D; Petrovic S; Elmaleh H; Fourneaux C; Bugnazet D; Duffieux F; Masiero A; Mitra-Kaushik S; Genet B; Fromentin Y; Kreiss P; Laborderie B; Brault D; Menet JM
    Biotechnol Bioeng; 2020 Nov; 117(11):3368-3378. PubMed ID: 32706388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.
    Vrooman LM; Kirov II; Dreyer ZE; Kelly M; Hijiya N; Brown P; Drachtman RA; Messinger YH; Ritchey AK; Hale GA; Maloney K; Lu Y; Plourde PV; Silverman LB
    Pediatr Blood Cancer; 2016 Feb; 63(2):228-33. PubMed ID: 26376459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asparaginase
    Gao C; Ma X; Zhang Z; Lu Q; Ashby CR; Wei L; Chen ZS
    Drugs Today (Barc); 2022 Jun; 58(6):261-271. PubMed ID: 35670704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase population PK-PD models.
    Avramis VI; Martin-Aragon S; Avramis EV; Asselin BL
    Anticancer Res; 2007; 27(4C):2561-72. PubMed ID: 17695416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.
    Figueiredo L; Cole PD; Drachtman RA
    Expert Rev Hematol; 2016 Mar; 9(3):227-34. PubMed ID: 26765930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.
    Pieters R; Hunger SP; Boos J; Rizzari C; Silverman L; Baruchel A; Goekbuget N; Schrappe M; Pui CH
    Cancer; 2011 Jan; 117(2):238-49. PubMed ID: 20824725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In brief: asparaginase Erwinia chrysanthemi (Erwinaze) for ALL.
    Med Lett Drugs Ther; 2012 Apr; 54(1388):32. PubMed ID: 22499236
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-Asparaginase.
    Modi T; Gervais D
    Invest New Drugs; 2022 Feb; 40(1):21-29. PubMed ID: 34468906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Characterisation of Non-Deamidated Acidic Variants of Erwinia chrysanthemi L-asparaginase Using Small-Angle X-ray Scattering and Ion-Mobility Mass Spectrometry.
    Gervais D; King D; Kanda P; Foote N; Elliott L; Brown P; Lee NO; Thalassinos K; Pizzey C; Rambo R; Minshull TC; Dickman MJ; Smith S
    Pharm Res; 2015 Nov; 32(11):3636-48. PubMed ID: 26040662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
    Huang Y; Molden R; Hu M; Qiu H; Li N
    J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid large-scale preparation of recombinant Erwinia chrysanthemi L-asparaginase.
    Goward CR; Stevens GB; Tattersall R; Atkinson T
    Bioseparation; 1992; 2(6):335-41. PubMed ID: 1368993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, real-time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma in Belgium.
    Mondelaers V; Ferster A; Uyttebroeck A; Brichard B; van der Werff Ten Bosch J; Norga K; Francotte N; Piette C; Vandemeulebroecke K; Verbeke C; Schmidt S; Benoit Y; Lammens T; De Moerloose B
    Br J Haematol; 2020 Jul; 190(1):105-114. PubMed ID: 32057100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.
    Duval M; Suciu S; Ferster A; Rialland X; Nelken B; Lutz P; Benoit Y; Robert A; Manel AM; Vilmer E; Otten J; Philippe N
    Blood; 2002 Apr; 99(8):2734-9. PubMed ID: 11929760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.